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The study was to investigate the effect of soya bean on the absorption of pefloxacin when given by 
oral route in rats. The first group of animals feeding on standard pellet feeds was given pefloxacin 
(8 mg/kg, p.o), while the second and third groups were also given the drug at the same dosage 
level but were fed with 50 % and 100 % soya bean respectively. Plasma samples were collected at 
different time intervals following drug administration. The concentrations of pefloxacin in plasma 
were determined using spectrophotometric method. Feeds with 50 % and 100 % soya bean 
respectively, gave significant increase (P<0.05) in the mean maximum plasma concentration 
(Cmax), mean area under the plasma concentration-time curve (AUC)  compared to those obtained 
for standard pellet feeds alone. No significant change in the mean time to reach maximum 
concentration (Tmax) was observed in all the tests. The results suggest an increase in the total 
absorption of pefloxacin by soya bean. 
 




The rate and extent to which an orally administered 
drug is absorbed depend on its physicochemical 
properties as well as various interactions between 
the drug and the gastrointestinal tract (Gibaldi and 
Feldman, 1970; Levy, 1972; Chasseaud and Taylor, 
1974). Food components can act on the release 
from dosage form as well as on the absorption of 
drugs. Potentially, food may interfere with tablet 
disintegration, drug dissolution and drug transport 
through the gastrointestinal tract. Several studies 
have reported the influence of standard meals or 
food components on drug absorption (Levine, 1970; 
Welling, 1977; Toothaker and Welling, 1980; Kirk, 
1995; Jefferson, 1998; Leibovitch et al., 2004). 
Pefloxacin,1,4-dihydro-7-(4-methylpiperazinyl)-4-
oxo-3-quinoline carboxylic acid is a second 
generation fluoroquinolone antibacterial agent. It 
acts by inhibiting DNA synthesis through cleavage 
of bacterial DNA in the DNA-enzyme complexes of 
DNA gyrase and type iv topoisomerase, resulting in 
rapid bacterial death (Hooper, 1999). Pefloxacin 
absorption, metabolism and mechanism of renal 
elimination in animals and humans have been 
reported to be influenced by food and antacid 
(Montay et al., 1984; Ulrich et al., 1994). Soya bean 
(Glycine max), in various preparations serves as an 
important source of protein in diets to various 
peoples of the world. Locally, soya bean serves as 
an ingredient in preparing foods for diabetic 
patients and as a good beverage for many 
households.  In this investigation, the influence of 
soya bean on pefloxacin absorption was studied. 
Soya bean was chosen because of the reasons 
already cited and literature review has shown little 
or no study on its effect on pefloxacin absorption. 
Pefloxacin was chosen for the study, because it is 
used for various disease states such as infections of 
the respiratory and urinary tracts, skin and soft 
tissue, gastrointestinal tract as well as severe 
systemic infections. 
 
Materials and Methods 
 
Materials: Pefloxacin mesylate was obtained from 
Fidson Healthcare Ltd, Nigeria while soya bean was 
purchased from Nsukka central market in Enugu 





Preparation of samples: Pefloxacin mesylate was 
prepared by suspending in 0.25 % w/v 
carboxymethyl cellulose while soya bean was 
prepared by drying in an oven at 50 oC and 
pulverizing with a mill. 
 
Pharmacokinetic study: In-house bred albino 
rats of either sex, weighing between 180-250 g 
were utilized for the study. The animals were 
housed in polypropylene cages and allowed access 
to food and water. In one group of rats (n=4) 
feeding on standard pellet diet (poultry growers 
feed), pefloxacin (8 mg/kg, p.o) was administered 
orally. The other group of rats- 2nd and 3rd groups, 
(n=4) were fed on 50 % (standard pellet diet: soya 
bean, 1:1) and 100 % soya bean respectively, and 
also received pefloxacin at the dosage level as the 
1st group of animals. Blood samples (0.5 ml) were 
collected in tubes containing 1 mg of ethylene 
diamine tetra acetic acid sodium (EDTA sodium) 
through microcapillary technique from retro-orbital 
plexus (Sorg and Buckner, 1964) under light ether 
anesthesia before treatment with pefloxacin and 
thereafter at 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 
10.0, 12.0 and 24.0 h after oral administration of 
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pefloxacin. Plasma samples after centrifugation (10 
min, 3000 rev/min), were deproteinized with 
acetonitrile. The plasma/acetonitrile mixture was 
allowed to stand for 10 min before centrifuging at 
5000 rev/min for 10 min. The upper layer was 
separated and used for the determination of 
pefloxacin levels. 
 
Determination of plasma pefloxacin 
concentration: The plasma concentrations of 
pefloxacin were determined by ultra violet 
spectrophotometric method at maximum 
wavelength of 280 nm. The standard curve 
constructed using deproteinized plasma was linear 
in the range of 0.5-10 μg/ml. Quantification of 
pefloxacin in rat plasma was done by reading the 
analyte response against the calibration curve. 
 
Recovery: Recovery of pefloxacin from plasma 
was obtained using 1.0-5.0 µg/ml concentrations by 
comparing absorbance of spiked deproteinized 
standards with those of corresponding 
concentration in acetonitrile. 
 
Analysis of data: The area under the plasma 
concentration-time curve (AUC) to the last sampling 
time was estimated by the linear trapezoidal 
method. The maximum concentration (Cmax) and 
maximum time (Tmax) were obtained directly from 
the generated data. The elimination constants (k) 
and terminal half-lives were calculated from the log-
linear part of the slope. The differences between 
the three respective treatment groups were 
analyzed for significance using student’s t-test. P 
values equal to or less than 0.05 were considered 
significant.   
 
Results and Discussion 
 
The regression equation describing the absorbance 
versus concentration relationship is A = 0.113C + 
0.062 (r = 0.9934). The recovery analysis (Table 1) 
shows that the solvent was effective in extracting 
pefloxacin from the spiked plasma.  
 
Table 1: Recovery of pefloxacin from the 
plasma samples 
Concentration  














91.51 ± .008 
99.35 ± 0.127 
94.90 ± .060 
87.90 ± 0.093 







The relative extent of bioavailability of pefloxacin in 
the presence of 50 % and 100 % soya bean 
respectively, was significantly (p<0.05) greater 
than that of pefloxacin in the presence of standard 





























Fig. 1: Plasma level-time profile for
standard pellet feed, 50 % soya bean feed 
and 100 % soya bean feed. Each point

























standard pellet feeds 
50 % soya bean feeds 
100 % soya bean feeds 
 
This was reflected by a mean increase of 25 % and 
31 % in area under the curve  (AUC 0→24) when 
pefloxacin was given with 50 % and 100 % soya 
bean respectively. It was also noted that the 
pefloxacin peak plasma concentration was 
increased by 23 % when given with 50 % soya 
bean or by 28 % when given with 100 % soya 
bean. There was no significant change in the time 
to reach peak plasma concentration, a rough 
estimate of absorption rate. The rest of the 
pharmacokinetic parameters are presented in Table 
2.  
Any co-administered treatment influencing 
the rate of gastric emptying of orally administered 
drug should be considered as potentially affecting 
the rate of absorption. Although, food has been 
found as a factor modifying drug absorption by 
delaying the gastric emptying rate (Melander, 
1978), soya bean may not have modified pefloxacin 
absorption by this mechanism since the time to 
peak concentration was not significantly affected in 
the study. The probable mechanism of action could 
either be the formation of aggregates that could 
associate with and solubilize pefloxacin molecules, 
or reduction in the contact angle between the drug 
and the gastrointestinal fluids by increasing the 
effective surface area of pefloxacin particles. 
Another probable mechanism could be a change in 
the pH of the environment of the dissolved drug.  
 
Conclusion: Pefloxacin absorption was significantly 
increased in rats fed with soya bean. The results of 
this investigation would suggest that the extent of 
pefloxacin absorption could be increased by as 
much as 31 % in the presence of soya bean. 
 
 
Effect of soya bean (Glycine max) on pefloxacin absorption in rats 
 
699
Table 2: Plasma pharmacokinetic parameters of pefloxacin (8 mg/kg, p.o) administered alone or 
together with soya bean in rats 
Parameter 
 
Standard pellets feeds 
(Treatment group I) 
50 % soya bean feeds 
(Treatment group II) 







4.31 ± 0.404 
2.9 ± 0.513 
31.73 ± 0.661 
14.6 ± 1.907 
5.63 ± 0.658 
2.7 ± 0.532 
42.27 ± 0.878 
14.4 ± 0.847 
5.73 ± 0.568 
3.0 ± 0.462 
46.12 ± 0.649 
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